Biopharma

Decline in BMI, Waist Circumference Seen in Decade Before Dementia

Decline in BMI, Waist Circumference Seen in Decade Befo...

Feb 9, 2025 0

FRIDAY, Feb. 7, 2025 -- Lower body mass index (BMI) and waist circumference and ...

Low Vitamin D in First Trimester Tied to Worse Outcomes

Low Vitamin D in First Trimester Tied to Worse Outcomes

Feb 9, 2025 0

FRIDAY, Feb. 7, 2025 -- Low vitamin D levels during the first trimester of pregn...

Nutrition Label Policies May Have Negative Impact on People With Eating Disorders

Nutrition Label Policies May Have Negative Impact on Pe...

Feb 9, 2025 0

FRIDAY, Feb. 7, 2025 -- Out-of-home nutrition label policies have a potential ne...

Opportunistic Salpingectomy During Any Abdominal Surgery Reduces Ovarian Cancer Risk

Opportunistic Salpingectomy During Any Abdominal Surger...

Feb 9, 2025 0

FRIDAY, Feb. 7, 2025 -- Opportunistic salpingectomy (OS) during any suitable abd...

Tonsillectomy Effective for Nocturnal Enuresis in Children With Sleep Apnea

Tonsillectomy Effective for Nocturnal Enuresis in Child...

Feb 9, 2025 0

FRIDAY, Feb. 7, 2025 -- For children with obstructive sleep apnea (OSA) with noc...

Study Finds Exenatide Not Beneficial for Parkinson Disease

Study Finds Exenatide Not Beneficial for Parkinson Disease

Feb 9, 2025 0

FRIDAY, Feb. 7, 2025 -- The glucagon-like peptide-1 receptor agonist exenatide d...

Live Birth Rate Lower With Frozen Versus Fresh Embryo Transfer

Live Birth Rate Lower With Frozen Versus Fresh Embryo T...

Feb 9, 2025 0

FRIDAY, Feb. 7, 2025 -- Frozen embryo transfer is associated with a lower live b...

FDA Approves Vtama (tapinarof) Cream for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

FDA Approves Vtama (tapinarof) Cream for the Treatment ...

Feb 9, 2025 0

JERSEY CITY, N.J.--(BUSINESS WIRE) December 16, 2024 -- Organon (NYSE: OGN), a ...

Galderma Receives U.S. FDA Approval for Nemluvio (nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis

Galderma Receives U.S. FDA Approval for Nemluvio (nemol...

Feb 9, 2025 0

Zug, Switzerland – December 13, 2024 – Galderma today announced that the United ...

FDA Approves Crenessity (crinecerfont) for the Treatment of Children and Adults with Classic Congenital Adrenal Hyperplasia

FDA Approves Crenessity (crinecerfont) for the Treatmen...

Feb 9, 2025 0

SAN DIEGO, Dec. 13, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: N...

FDA Approves Unloxcyt (cosibelimab-ipdl) for the Treatment of Cutaneous Squamous Cell Carcinoma

FDA Approves Unloxcyt (cosibelimab-ipdl) for the Treatm...

Feb 9, 2025 0

WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ...

Imfinzi Approved in the US as First and Only Immunotherapy Regimen for Patients with Limited-Stage Small Cell Lung Cancer

Imfinzi Approved in the US as First and Only Immunother...

Feb 9, 2025 0

5 December 2024 -- AstraZeneca’s Imfinzi (durvalumab) has been approved in the U...

FDA Grants Accelerated Approval to Bizengri (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer

FDA Grants Accelerated Approval to Bizengri (zenocutuzu...

Feb 9, 2025 0

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 04, 2024 (GLOBE NEWSWIRE) --...

FDA Approves Yesintek (ustekinumab-kfce), a Biosimilar to Stelara

FDA Approves Yesintek (ustekinumab-kfce), a Biosimilar ...

Feb 9, 2025 0

Bengaluru, Karnataka, India, December 01, 2024 -- Biocon Biologics Ltd (BBL), a ...

FDA Approves Rapiblyk (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting

FDA Approves Rapiblyk (landiolol) for Atrial Fibrillati...

Feb 9, 2025 0

Vienna, -- November 27th 2024 -- AOP Orphan Pharmaceuticals GmbH (AOP Health), b...

FDA Approves Imkeldi (imatinib) Oral Solution for the Treatment of Certain Forms of Leukemia and Other Cancers

FDA Approves Imkeldi (imatinib) Oral Solution for the T...

Feb 9, 2025 0

CAMBRIDGE, Mass.-- November 25, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Irelan...

Increase Seen in Cases of Schizophrenia Linked to Cannabis Use Disorder

Increase Seen in Cases of Schizophrenia Linked to Canna...

Feb 9, 2025 0

FRIDAY, Feb. 7, 2025 -- The proportion of incident cases of schizophrenia associ...

Tevimbra Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy

Tevimbra Approved in U.S. for First-line Treatment of G...

Feb 9, 2025 0

SAN MATEO, Calif.--(BUSINESS WIRE)-- December 27, 2024 -- BeiGene, Ltd. (NASDAQ:...

Sumitomo Pharma America Announces U.S. FDA Approval of Gemtesa (vibegron) for Men with Overactive Bladder Symptoms Receiving Pharmacological Therapy for Benign Prostatic Hyperplasia

Sumitomo Pharma America Announces U.S. FDA Approval of ...

Feb 9, 2025 0

MARLBOROUGH, Mass., Dec. 23, 2024 /PRNewswire/ -- Sumitomo Pharma America, Inc. ...

FDA Approves Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) for the Treatment of Cystic Fibrosis

FDA Approves Alyftrek (vanzacaftor/tezacaftor/deutivaca...

Feb 9, 2025 0

BOSTON--(BUSINESS WIRE)--Dec. 20, 2024-- Vertex Pharmaceuticals Incorporated (Na...

U.S. FDA Approves Pfizer’s Braftovi Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer

U.S. FDA Approves Pfizer’s Braftovi Combination Regimen...

Feb 9, 2025 0

NEW YORK--(BUSINESS WIRE) December 20, 2024 -- Pfizer Inc. (NYSE: PFE) today ann...

FDA Approves Zepbound (tirzepatide) as the First and Only Prescription Medicine for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity

FDA Approves Zepbound (tirzepatide) as the First and On...

Feb 9, 2025 0

INDIANAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) to...

FDA Approves Alhemo (concizumab-mtci) to Prevent or Reduce Bleeding Episodes in People with Hemophilia A or B with Inhibitors

FDA Approves Alhemo (concizumab-mtci) to Prevent or Red...

Feb 9, 2025 0

PLAINSBORO, N.J., Dec. 20, 2024 /PRNewswire/ -- Novo Nordisk announced today tha...

Rhythm Pharmaceuticals Announces FDA Approval of Imcivree (setmelanotide) for Patients as Young as 2 Years Old

Rhythm Pharmaceuticals Announces FDA Approval of Imcivr...

Feb 9, 2025 0

BOSTON, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: ...

56
57
58
59
60

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.